Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hagedoorn

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Journal of Aerosol Medicine and Pulmonary Drug Delivery|March 21, 2013
Challenging the two-minute tidal breathing challenge testAnne J Lexmond, Paul Hagedoorn, Henderik W Frijlink, et al.
Pharmaceutics|July 15, 2020
Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops<sup>®</sup> High Dose Dry Powder Inhalation Device While Maintaining DispersibilityImco Sibum, Paul Hagedoorn, Carel O Botterman, et al.
Current Pharmaceutical Design|October 9, 2015
Recent advances in the fundamental understanding of adhesive mixtures for inhalationFloris Grasmeijer, Niels Grasmeijer, Paul Hagedoorn, et al.
International Journal of Pharmaceutics|July 12, 2018
Challenges for pulmonary delivery of high powder dosesImco Sibum, Paul Hagedoorn, Anne Haaije de Boer, et al.
Plos One|August 12, 2017
Prerequisites for a dry powder inhaler for children with cystic fibrosisAnne J Lexmond, Paul Hagedoorn, Henderik W Frijlink, et al.
Pharmaceutical Research|January 15, 2005
The mode of drug particle detachment from carrier crystals in an air classifier-based inhalerAnne H de Boer, Paul Hagedoorn, Doetie Gjaltema, et al.
Pharmaceutics|December 29, 2019
Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or TrileucineImco Sibum, Paul Hagedoorn, Markus P G Kluitman, et al.
Pharmaceutical Research|January 15, 2005
The rate of drug particle detachment from carrier crystals in an air classifier-based inhalerAnne H de Boer, Paul Hagedoorn, Doetie Gjaltema, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 11, 2015
A levodopa dry powder inhaler for the treatment of Parkinson's disease patients in off periodsMarianne Luinstra, Floris Grasmeijer, Paul Hagedoorn, et al.
Pharmaceutics|September 27, 2025
An In Vitro-In Vivo Comparison of Two Levodopa Dry Powder Products for Inhalation: A Randomized Trial Comparing Inbrija and Levodopa CyclopsJulia M E Berends, Ettina J Wimmenhove, Marcel Hoppentocht, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Aerosol Medicine and Pulmonary Drug Delivery|March 21, 2013
Challenging the two-minute tidal breathing challenge testAnne J Lexmond, Paul Hagedoorn, Henderik W Frijlink, et al.
Pharmaceutics|July 15, 2020
Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops<sup>®</sup> High Dose Dry Powder Inhalation Device While Maintaining DispersibilityImco Sibum, Paul Hagedoorn, Carel O Botterman, et al.
Current Pharmaceutical Design|October 9, 2015
Recent advances in the fundamental understanding of adhesive mixtures for inhalationFloris Grasmeijer, Niels Grasmeijer, Paul Hagedoorn, et al.
International Journal of Pharmaceutics|July 12, 2018
Challenges for pulmonary delivery of high powder dosesImco Sibum, Paul Hagedoorn, Anne Haaije de Boer, et al.
Plos One|August 12, 2017
Prerequisites for a dry powder inhaler for children with cystic fibrosisAnne J Lexmond, Paul Hagedoorn, Henderik W Frijlink, et al.
Pharmaceutical Research|January 15, 2005
The mode of drug particle detachment from carrier crystals in an air classifier-based inhalerAnne H de Boer, Paul Hagedoorn, Doetie Gjaltema, et al.
Pharmaceutics|December 29, 2019
Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or TrileucineImco Sibum, Paul Hagedoorn, Markus P G Kluitman, et al.
Pharmaceutical Research|January 15, 2005
The rate of drug particle detachment from carrier crystals in an air classifier-based inhalerAnne H de Boer, Paul Hagedoorn, Doetie Gjaltema, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 11, 2015
A levodopa dry powder inhaler for the treatment of Parkinson's disease patients in off periodsMarianne Luinstra, Floris Grasmeijer, Paul Hagedoorn, et al.
Pharmaceutics|September 27, 2025
An In Vitro-In Vivo Comparison of Two Levodopa Dry Powder Products for Inhalation: A Randomized Trial Comparing Inbrija and Levodopa CyclopsJulia M E Berends, Ettina J Wimmenhove, Marcel Hoppentocht, et al.
Pageof 5